{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-005536","form_type":"8-K","ticker":"BDSX","cik":"0001439725","company_name":"BIODESIX INC","filed_at":"2022-04-11T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.733195+00:00","generated_at":"2026-06-26T08:12:17.148712+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Biodesix raises $11.7M via private placement; amends 2021 term loan with SVB","bullets":["Sold 6,508,376 shares at $1.79/share to consortium including board members, raising ~$11.7M.","Third Amendment to 2021 Term Loan: repays $3M in April 2022 and $2M later; waives Q1 2022 minimum revenue requirement.","Waiver of prepayment fee on $3M repayment; consent for $2M milestone payment under Integrated Diagnostics purchase agreement.","Reaffirms 2022 revenue guidance of $37.5M-$39.5M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-005536","json":"https://secwatch.observer/filing/0000950170-22-005536.json","markdown":"https://secwatch.observer/filing/0000950170-22-005536.md","text":"https://secwatch.observer/filing/0000950170-22-005536.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1439725/000095017022005536/0000950170-22-005536-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1439725/000095017022005536/bdsx-20220407.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T08:12:17.148712+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}